IDEAYA Biosciences, Inc.
NASDAQIDEAYA Biosciences reports Monday after the close with short sellers pulling back from recent highs — yet the dominant shift heading into the print is a sharp rotation toward bullish options positioning. The options market has turned notably more optimistic over the past two weeks. The put/call ratio has dropped to 0.77, roughly one standard deviation below its 20-day average of…
Snapshot as of 27 Jun 2026
IDEAYA Biosciences reports Monday after the close with short sellers pulling back from recent highs — yet the dominant shift heading into the print is a sharp rotation toward bullish options positioning. The options…
IDEAYA Biosciences heads into its May 6 earnings release with a noteworthy split between short sellers building exposure and options traders positioned for upside rather than protection. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IDYA — free to start on ORTEX.
Sign up for free →Open IDYA on ORTEX